Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CES1 | P23141 | 2/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.46 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL11615478 | 0.92 | TSHR (0.50) | TSHRCES1CES2AKR1B1CYP1A2 | |
| SCHEMBL13197240 | 0.88 | POLB (0.45) | TSHRCES1CES2AKR1B1CYP1A2 | |
| SCHEMBL2625190 | 0.88 | LMNA (0.62) | TSHRCYP1A2KMT2AMEN1CYP2D6 | |
| SCHEMBL21099952 | 0.84 | ITGA4 (0.48) | TSHRCES1CES2AKR1B1CYP1A2 | |
| SCHEMBL4725179 | 0.84 | TSHR (0.55) | TSHRCES1CES2AKR1B1CYP1A2 | |
| SCHEMBL107178 | 0.84 | TSHR (0.55) | TSHRCES1CES2AKR1B1CYP1A2 | |
| SCHEMBL10137814 | 0.84 | CA2 (0.56) | TSHRAKR1B1POLBKMT2AMEN1 | |
| SCHEMBL12908027 | 0.84 | TSHR (0.50) | TSHRCES1CES2AKR1B1CYP1A2 | |
| SCHEMBL12267745 | 0.83 | PTGS2 (0.51) | ITGA4ITGB7 | |
| SCHEMBL14462168 | 0.83 | MAPT (0.48) | TSHRCYP1A2POLBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 587 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163014-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-22 | — | — | US | claimed |
| EP-4491621-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-01-15 | — | — | EP | claimed |
| CN-118829634-A | Method for producing episulfide compound | 三菱瓦斯化学株式会社 | 2024-10-22 | — | — | CN | claimed |
| WO-2023171591-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | 三菱瓦斯化学株式会社 | 2023-09-14 | — | — | WO | claimed |
| CN-108929400-B | Nickel catalyst system, high-performance polybutadiene and preparation method thereof | 北京化工大学 | 2023-03-14 | — | — | CN | claimed |
| US-11528912-B2 | Bacillus methylotrophicus strain DR-08 producing natural volatile compound and having antibacterial activity, and use thereof | GLOBAL AGRO CO., LTD. (KR) | 2022-12-20 | — | — | US | claimed |
| US-20190166849-A1 | BACILLUS METHYLOTROPHICUS STRAIN DR-08 PRODUCING NATURAL VOLATILE COMPOUND AND HAVING ANTIBACTERIAL ACTIVITY, AND USE THEREOF | GLOBAL AGRO CO., LTD. (KR) | 2019-06-06 | — | — | US | claimed |
| EP-3492580-A1 | BACILLUS METHYLOTROPHICUS STRAIN DR-08 PRODUCING NATURAL VOLATILE COMPOUND AND HAVING ANTIBACTERIAL ACTIVITY, AND USE THEREOF | Global Agro Co., Ltd. (KR) | 2019-06-05 | — | — | EP | claimed |
| CN-108929400-A | A kind of nickel catalyst system, high-performance polybutadiene and preparation method thereof | 北京化工大学 | 2018-12-04 | — | — | CN | claimed |
| US-20250163014-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-4547683-A2 | CYCLIC-DISULFIDE MODIFIED PHOSPHATE BASED OLIGONUCLEOTIDE PRODRUGS | Alnylam Pharmaceuticals, Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| EP-4491621-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-01-15 | — | — | EP | disclosed |
| EP-4462501-A2 | SLURRY FOR FORMING NEGATIVE ELECTRODE ACTIVE MATERIAL LAYER SLURRY, NEGATIVE ELECTRODE ACTIVE MATERIAL LAYER, AND SOLID-STATE BATTERY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2024-11-13 | — | — | EP | disclosed |
| US-20240368001-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-11-07 | — | — | US | disclosed |
| EP-0325130-A2 | Substituted pyridines | BAYER AG (DE) | 1989-07-26 | — | — | EP | disclosed |
| EP-0317845-A2 | Substituted hydroxyl amines | BAYER AG (DE) | 1989-05-31 | — | — | EP | disclosed |
| EP-0300278-A2 | Process for the preparation of 2-substituted pyrroles | BAYER AG (DE) | 1989-01-25 | — | — | EP | disclosed |
| EP-0267794-A2 | Process for preparing polyolefins | Nippon Petrochemicals Co., Ltd. (JP) | 1988-05-18 | — | — | EP | disclosed |
| US-3975373-A | CYCLOPENTANONE HELVETICOSIDE | JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) | 1976-08-17 | — | — | US | disclosed |
| US-3951946-A | Cardioglycoside derivatives of the strophanthidin type, a process for their manufacture and medicinal preparations containing these compounds | JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163014-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | SULT1E1, ESR2, MRPL21 | TSHR 2688/4885CES1 526/4885CES2 709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.